朗詩綠色集團(00106.HK)根據合作協議回購目標股權及信託債權 涉資4265.72萬元
格隆匯11月14日丨朗詩綠色集團(00106.HK)發佈公告,有關西安朗詩銘與百瑞信託為共同開發目標地塊而訂立的合作協議,並於滿足約定條件的情況下,西安朗詩銘同意對目標股權及信託債權進行回購。公司全資附屬公司西安朗詩銘於2019年11月14日接獲百瑞信託有關要求西安朗詩銘按該協議約定條件對目標股權及信託債權進行回購的通知,總代價為人民幣4265.72萬元,總代價為根據百瑞信託對西安朗詩意及/或目標公司進行股權投資、增資及債權融資總金額人民幣3929.8萬元以及應收利息按照年化利率12%釐定,計息天數260天,利息金額共計人民幣335.92萬元而定,並已於2019年11月14日完成回購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.